Phase II Activity of Belinostat (PXD-101), Carboplatin, and Paclitaxel in Women With Previously Trea...
Phase II Activity of Belinostat (PXD-101), Carboplatin, and Paclitaxel in Women With Previously Treated Ovarian Cancer
About this item
Full title
Author / Creator
Publisher
United States: Copyright by IGCS and ESGO
Journal title
Language
English
Formats
Publication information
Publisher
United States: Copyright by IGCS and ESGO
Subjects
More information
Scope and Contents
Contents
BACKGROUNDPreclinical data show that belinostat (Bel) is synergistic with carboplatin and paclitaxel in ovarian cancer. To further evaluate the clinical activity of belinostat, carboplatin, and paclitaxel (BelCaP), a phase 1b/2 study was performed, with an exploratory phase 2 expansion planned specifically for women with recurrent epithelial ovaria...
Alternative Titles
Full title
Phase II Activity of Belinostat (PXD-101), Carboplatin, and Paclitaxel in Women With Previously Treated Ovarian Cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2552831743
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2552831743
Other Identifiers
ISSN
1048-891X
E-ISSN
1525-1438
DOI
10.1097/IGC.0b013e31825736fd
